
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0465 | -7.86535859269 | 0.5912 | 0.6978 | 0.53 | 3596285 | 0.59283896 | CS |
4 | -0.0653 | -10.7049180328 | 0.61 | 0.6978 | 0.53 | 2934016 | 0.58809028 | CS |
12 | -1.6353 | -75.0137614679 | 2.18 | 2.44 | 0.53 | 7543651 | 1.10887497 | CS |
26 | -5.3553 | -90.7677966102 | 5.9 | 10.6237 | 0.53 | 4856653 | 3.42428079 | CS |
52 | -4.6153 | -89.4437984496 | 5.16 | 10.6237 | 0.53 | 3001078 | 3.85566651 | CS |
156 | -1.6653 | -75.3529411765 | 2.21 | 10.6237 | 0.4995 | 1400639 | 3.38435648 | CS |
260 | -41.2053 | -98.6953293413 | 41.75 | 51.99 | 0.4995 | 901871 | 4.72255763 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales